Showing results (391-400 of 515) with videos related to
Sort By:
Pageof 52
American Journal of Infection Control|April 5, 2015
An electronic surveillance tool for catheter-associated urinary tract infection in intensive care unitsHeather E Hsu, Erica S Shenoy, Douglas Kelbaugh, et al.Nature Communications|July 28, 2025
Environmental cues in different host niches shape the survival fitness of Staphylococcus aureusJuOae Chang, ChaeYoung Lee, Inseo Kim, et al.Infection Control and Hospital Epidemiology|February 18, 2026
Current infection control practices for multidrug-resistant organisms (MDRO): a survey of the Society for Healthcare Epidemiology of America (SHEA) research network and affiliated US-based hospitalsK C Coffey, Trudy Grossman, David B Banach, et al.Antimicrobial Agents and Chemotherapy|June 20, 2018
Genes and Proteins Involved in qnrS1 InductionRubén Monárrez, Yin Wang, Yingmei Fu, et al.Lasers in Surgery and Medicine|March 14, 2002
Laser-induced shock waves enhance sterilization of infected vascular prosthetic graftsG R Nigri, S Tsai, S Kossodo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 1998
The epidemiology of resistance to ofloxacin and oxacillin among clinical coagulase-negative staphylococcal isolates: analysis of risk factors and strain typesD A Pegues, C Colby, P L Hibberd, et al.American Journal of Epidemiology|January 24, 1998
Relation of three genetic traits to venous thrombosis in an African-American populationA Dilley, H Austin, W C Hooper, et al.Leukemia|December 1, 1990
Studies of myeloperoxidase gene expression at the cellular level by in situ hybridizationS R Zaki, G E Austin, D C Swan, et al.Chest|October 26, 1999
The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African AmericansW C Hooper, C Lally, H Austin, et al.Vaccine|June 28, 2001
Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxisC A Hanlon, C A DeMattos, C C DeMattos, et al.Pageof 52